Please assess the completion status of the following clinical trial:

Trial Title: The Relationship of Hemoglobin A1c and Diabetic Wound Healing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* \>18 years of age~* Diabetic (Type I and Type II)~* Ulceration of the foot at least one centimeter in width/length~* Ulceration at least 0.2 centimeters in depth~Exclusion Criteria:~* Ulceration width/length \> 7.5 centimeters~* Wound depth \> 1.25 centimeters~* Purulent, excessive drainage and/or other signs of infection (i.e. erythema, edema, warmth)~* Inability to provide informed consent~* Inability to swallow pills (vitamin C supplement)~* Patients with concurrent renal problems~* Patients with medication contraindications to Vitamin C and/or topical wound dressings

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bacitracin wound care dressing alone (Type: ACTIVE_COMPARATOR): Bacitracin wound care dressing alone
- Bacitracin with Vit C (Type: ACTIVE_COMPARATOR): Bacitracin wound care dressing with Vitamin C supplementation
- AmeriGel® wound care dressing alone (Type: ACTIVE_COMPARATOR): AmeriGel® wound care dressing alone
- AmeriGel® with Vit C (Type: ACTIVE_COMPARATOR): AmeriGel® wound care dressing with Vitamin C supplementation

Based on this trial design, predict the completion outcome and termination type (if applicable).